- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06570122
Mobile Phone-Based Smoking-Cessation Intervention for Smoking Parents
Effectiveness of AI-powered Mobile Phone-based Interventions in Parental Smoking Cessation
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Parental smoking is associated with numerous adverse outcomes, including exposure to secondhand smoke, heightened risk of respiratory illnesses in children, and an increased likelihood that children will adopt smoking behaviors themselves. Despite awareness of these risks, many parents find it challenging to quit smoking due to stress, lack of support, and time constraints.
This randomized controlled trial (RCT) investigates the effectiveness of a mobile phone-based intervention tailored specifically for smoking parents. The intervention group will receive AI-powered chatbot cessation support, while the control group will be provided with brief cessation advice. The study aims to determine whether the AI-driven intervention is more effective in helping parents quit smoking compared to traditional brief advice.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Xue Weng
- Phone Number: 3621259
- Email: xueweng@bnu.edu.cn
Study Locations
-
-
Guangdong
-
Zhuhai, Guangdong, China, 519087
- Beijing Normal University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- aged 18 and above, reside in Zhuhai for the next 6 months
- smoke at least 1 cigarette or use e-cigarettes daily
- have a smartphone and a WeChat account, able to use WeChat skillfully
Exclusion Criteria:
- Smokers who have communication barrier (either physically or cognitively)
- Smokers who are currently participating in other SC programmes or services
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: AI chatbot support group
AI-powered chatbot support+ 5A's/5R's advice + health warning leaflet
|
5A's (Ask, Advise, Assess, Assist, Arrange) for smokers who are ready to quit, and 5R's (relevance, risks, rewards, roadblocks, and repetition) for smokers who are not ready to quit.
The health warning leaflet provides essential information on the dangers of secondhand and thirdhand smoke.
It outlines how exposure to these forms of smoke can harm both smokers and non-smokers, particularly children, by increasing the risk of respiratory illnesses and other health issues.
Participants will receive three months of AI-powered chatbot, equipped with personalized interactions and real-time support, via WeChat.
|
|
Active Comparator: Control group
5A's/5R's advice + health warning leaflet
|
5A's (Ask, Advise, Assess, Assist, Arrange) for smokers who are ready to quit, and 5R's (relevance, risks, rewards, roadblocks, and repetition) for smokers who are not ready to quit.
The health warning leaflet provides essential information on the dangers of secondhand and thirdhand smoke.
It outlines how exposure to these forms of smoke can harm both smokers and non-smokers, particularly children, by increasing the risk of respiratory illnesses and other health issues.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-reported 7-day point prevalence quit rate
Time Frame: 3 and 6 months follow-up
|
Self-reported 7-day point prevalence quit rate in the two groups
|
3 and 6 months follow-up
|
|
Eligibility rate
Time Frame: baseline
|
the percentage of eligible smokers out of the total number of smokers screened
|
baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Consent rate
Time Frame: baseline
|
the percentage of eligible smokers who agree to participate out of the total number of eligible smokers
|
baseline
|
|
Percentage of Participant Engagement with E-Messages and Counselor Chats
Time Frame: 3 months follow-up
|
This outcome measures the percentage of participants who engage with the intervention by reading e-messages and responding to counselor chat messages at least once during the 3-month follow-up period.
|
3 months follow-up
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- mCessation in smoking parents
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking Cessation
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
National University of SingaporeRecruitingSmoking &Amp; Tobacco CessationSingapore
-
Nabi BiopharmaceuticalsNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco CessationUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Heidelberg UniversityPfizerTerminatedSmoking | Smoking Cessation | Tobacco Use CessationGermany
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedSmoking &Amp; Tobacco CessationUnited States
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Sultan Qaboos UniversityCompletedSmoking Cessation | Tobacco Use Cessation | Smoking PreventionOman
-
University of VermontMayo Clinic; Alaska Native Tribal Health ConsortiumTerminatedSmoking | Smoking CessationUnited States
Clinical Trials on 5A's/5R's advice
-
Beijing Normal UniversityNot yet recruitingSmoking Cessation | Mobile HealthChina
-
Beijing Normal UniversityRecruiting
-
Beijing Normal UniversityActive, not recruiting
-
The Hong Kong Polytechnic UniversityRecruiting
-
American Academy of PediatricsNational Cancer Institute (NCI)CompletedTobacco Cessation | Media UseUnited States
-
American Academy of PediatricsNational Institute on Drug Abuse (NIDA)Completed
-
Kamuzu University of Health SciencesNational Heart, Lung, and Blood Institute (NHLBI)UnknownHypertension | Diabetes | Life StyleMalawi
-
Duke UniversityUniversity of PittsburghActive, not recruitingSmoking Cessation | Pregnancy | Communication ResearchUnited States
-
VU University of AmsterdamAmsterdam UMC, location VUmc; University of HelsinkiCompletedPhysical Disability | Protein-Energy MalnutritionFinland, Netherlands
-
Bournemouth UniversityEnrolling by invitationDietary Behavior | Free Sugar | Sweet TasteUnited Kingdom